Polymorphism of interleukin-6 -174 G/C (rs1800795) & the corresponding interleukin-6 level as a prognostic marker of cervical cancer
- PMID: 34854425
- PMCID: PMC9131768
- DOI: 10.4103/ijmr.IJMR_1111_19
Polymorphism of interleukin-6 -174 G/C (rs1800795) & the corresponding interleukin-6 level as a prognostic marker of cervical cancer
Abstract
Background & objectives: Aetiology of cervical cancer (CaCx) is multifactorial. Besides human papillomavirus (HPV) infection, many immunogenetic factors are involved in this complex process. The present study was carried out to investigate one such factor, interleukin-6 (IL-6), a central pro-inflammatory cytokine and a polymorphism at its promoter region -174 G/C (rs1800795) with CaCx.
Methods: HPV-infected women with or without CaCx were enrolled in group I and II, respectively. Another group of uninfected healthy women was also included as group III for comparison. Polymorphism in IL-6-174 G/C and IL-6 levels were analyzed by sequence-specific primer PCR (PCR-SSP) and ELISA, respectively.
Results: Groups I (n=111) and II (n=87) had significantly higher frequency of IL-6-174 GG genotype [odds ratios (OR)=3.9; P<0.001 and OR=3.2; P<0.001, respectively] as compared to group III (n=163). Furthermore, individuals with GG or GC genotypes had high IL-6 levels than those with CC genotypes. IL-6 levels were significantly (P<0.001) elevated in group I. This was also significantly high in untreated cases as compared to treated (P<0.05) ones. IL-6 levels of treated group were comparable with groups II and III.
Interpretation & conclusions: Our results suggested a possible association of IL-6-174 GG with CaCx, which was also associated with high IL-6 levels. Decreased levels of IL-6 following treatment indicate its possible prognostic use in CaCx cases.
Keywords: Cervical cancer; human papillomavirus; interleukin-6; prognostic marker; serum interleukin-6; single-nucleotide polymorphism.
Conflict of interest statement
None
Figures


Similar articles
-
IL-6 597A/G (rs1800797) and 174G/C (rs1800795) Gene Polymorphisms in the Development of Cervical Cancer in Lithuanian Women.Medicina (Kaunas). 2021 Sep 26;57(10):1025. doi: 10.3390/medicina57101025. Medicina (Kaunas). 2021. PMID: 34684062 Free PMC article.
-
Molecular Investigation of the Association Among Common Interleukin-6 Polymorphism and Human Papillomavirus Genotypes with Cervical Cancer Among Iranian Women.Monoclon Antib Immunodiagn Immunother. 2023 Aug;42(4):125-131. doi: 10.1089/mab.2022.0039. Monoclon Antib Immunodiagn Immunother. 2023. PMID: 37624608
-
Polymorphisms in cytotoxic T-lymphocyte associated antigen 4 gene does not affect scytotoxic T-lymphocyte associated antigen 4 levels in human papillomavirus-infected women with or without cervical cancer.Indian J Med Microbiol. 2018 Apr-Jun;36(2):207-210. doi: 10.4103/ijmm.IJMM_17_220. Indian J Med Microbiol. 2018. PMID: 30084412
-
Association of IL-12B rs3212227 and IL-6 rs1800795 Polymorphisms with Susceptibility to Cervical Cancer: A Systematic Review and Meta-Analysis.Asian Pac J Cancer Prev. 2020 May 1;21(5):1197-1206. doi: 10.31557/APJCP.2020.21.5.1197. Asian Pac J Cancer Prev. 2020. PMID: 32458622 Free PMC article.
-
Association of Polymorphisms in Cytokine genes with susceptibility to Precancerous Lesions and Cervical Cancer: A systematic review with meta-analysis.Immunol Invest. 2021 Jul;50(5):492-526. doi: 10.1080/08820139.2020.1778023. Epub 2020 Jun 30. Immunol Invest. 2021. PMID: 32602796
Cited by
-
Association of cytokine gene polymorphisms with peripheral neuropathy susceptibility in people living with HIV in Greece.J Neurovirol. 2023 Oct;29(5):626-639. doi: 10.1007/s13365-023-01169-5. Epub 2023 Sep 11. J Neurovirol. 2023. PMID: 37695541
-
Polymorphisms of the interleukin-6 (IL-6) gene contribute to cervical cancer susceptibility in Bangladeshi women: A case-control study.Health Sci Rep. 2023 May 3;6(5):e1238. doi: 10.1002/hsr2.1238. eCollection 2023 May. Health Sci Rep. 2023. PMID: 37152226 Free PMC article.
-
Association of interleukin6 rs1800796 gene polymorphism and serum level with bladder cancer in Egyptian population.Mol Biol Rep. 2024 Jul 15;51(1):815. doi: 10.1007/s11033-024-09791-0. Mol Biol Rep. 2024. PMID: 39009695
References
-
- World Health Organization. Global cancer observatory (GCO) data for cervical cancer. [assessed on October 10, 2020]. Available from:https://gco.iarc.fr/today/online-analysis-multibars?v=2020&mode=cancer&m... .
-
- Stanley M. Pathology and epidemiology of HPV infection in females. Gynecol Oncol. 2010;117:S5–10. - PubMed
-
- Zur Hausen H. Papillomaviruses and cancer:From basic studies to clinical application. Nat Rev Cancer. 2002;2:342–50. - PubMed
-
- Wang SS, Hildesheim A. Chapter 5:Viral and host factors in human papillomavirus persistence and progression. J Natl Cancer Inst Monogr. 2003;31:35–40. - PubMed
-
- Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest. 1998;102:1369–76. - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous